XENE Insider Transactions
357 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
XENE insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| GANNON STEVEN | Director | 2026-08-11 | Sale | 10,000 | $64.055 |
| PATOU GARY | Director | 2026-06-05 | Sale | 1,322.0 | $53.14 |
| Cannon Gillian | Director | 2026-06-05 | Sale | 1,190.0 | $53.14 |
| KENNEY CHRISTOPHER JOHN | Chief Medical Officer | 2026-03-13 | Sale | 1,410.0 | $55.23 |
| DiFabio Andrea | Chief Legal Officer | 2026-03-13 | Sale | 1,342.0 | $55.23 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-13 | Sale | 7,308.0 | $55.23 |
| KENNEY CHRISTOPHER JOHN | Chief Medical Officer | 2026-03-10 | Sale | 2,771.0 | $60.11 |
| DiFabio Andrea | Chief Legal Officer | 2026-03-10 | Sale | 2,607.0 | $60.11 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-10 | Sale | 11,269.0 | $60.11 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 65,000.0 | $62.06 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 61,652.0 | $60.08 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 43,348.0 | $59.26 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 2,449.0 | $61.26 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 10,072.0 | $60.47 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 12,479.0 | $59.5 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 21,515.0 | $60.49 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 31,694.0 | $59.88 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-03-09 | Sale | 21,791.0 | $58.81 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-01-02 | Sale | 2,062.0 | $44.93 |
| MORTIMER IAN | PRESIDENT & CEO | 2026-01-02 | Sale | 37,938.0 | $44.4 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-12-08 | Sale | 2,010.0 | $46.32 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-12-08 | Sale | 8,820.0 | $45.59 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-12-05 | Sale | 14,375.0 | $45.03 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-11-28 | Sale | 97.0 | $45.01 |
| MORTIMER IAN | PRESIDENT, CEO & INTERIM CFO | 2025-10-01 | Sale | 25,000.0 | $40.16 |
| GANNON STEVEN | Director | 2025-06-05 | Sale | 3.0 | $30.48 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-01-27 | Sale | 1,149.0 | $41.07 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-01-27 | Sale | 15,166.0 | $40.46 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-01-24 | Sale | 22,468.0 | $40.2 |
| MORTIMER IAN | PRESIDENT & CEO | 2025-01-23 | Sale | 16,217.0 | $40.08 |
| AULIN SHERRY | Chief Financial Officer | 2024-12-18 | Sale | 11,510.0 | $41.19 |
| AULIN SHERRY | Chief Financial Officer | 2024-12-18 | Sale | 7,199.0 | $41.23 |
| PATOU GARY | Director | 2024-11-22 | Sale | 2,040.0 | $41.05 |
| PATOU GARY | Director | 2024-11-22 | Sale | 2,851.0 | $41.11 |
| GAROFALO ELIZABETH A. | Director | 2024-03-08 | Sale | 2,092.0 | $45.69 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2024-03-07 | Sale | 6,118.0 | $46.3 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2024-03-07 | Sale | 1,019.0 | $46.15 |
| GANNON STEVEN | Director | 2024-03-07 | Sale | 2,000.0 | $46.2 |
| GANNON STEVEN | Director | 2024-03-07 | Sale | 5,000.0 | $46.3 |
| GANNON STEVEN | Director | 2024-03-07 | Sale | 5,000.0 | $46.25 |
| GANNON STEVEN | Director | 2024-03-07 | Sale | 1,000.0 | $46.45 |
| PATOU GARY | Director | 2023-12-14 | Sale | 7,598.0 | $41.05 |
| PATOU GARY | Director | 2023-12-13 | Sale | 7,598.0 | $41.05 |
| PATOU GARY | Director | 2023-12-13 | Sale | 3,977.0 | $39.84 |
| PATOU GARY | Director | 2023-12-13 | Sale | 2,303.0 | $39.1 |
| PATOU GARY | Director | 2023-12-13 | Sale | 5,100.0 | $38.94 |
| Svoronos Dawn | Director | 2023-08-24 | Sale | 25,000.0 | $38.7 |
| PIMSTONE SIMON N. | Director | 2023-06-01 | Sale | 24,255.0 | $38.78 |
| PIMSTONE SIMON N. | Director | 2023-06-01 | Sale | 7,458.0 | $38.97 |
| PIMSTONE SIMON N. | Director | 2023-05-31 | Sale | 26,856.0 | $38.69 |
| PIMSTONE SIMON N. | Director | 2023-05-31 | Sale | 23,670.0 | $38.81 |
| PIMSTONE SIMON N. | Director | 2023-05-31 | Sale | 12,000.0 | $38.53 |
| PIMSTONE SIMON N. | Director | 2023-05-30 | Sale | 19,000.0 | $39.9 |
| PIMSTONE SIMON N. | Director | 2023-05-30 | Sale | 18,006.0 | $38.63 |
| MORTIMER IAN | PRESIDENT & CEO | 2023-05-24 | Sale | 1,407.0 | $41.49 |
| MORTIMER IAN | PRESIDENT & CEO | 2023-05-24 | Sale | 13,179.0 | $41.37 |
| MORTIMER IAN | PRESIDENT & CEO | 2023-05-24 | Sale | 17,069.0 | $41.44 |
| KENNEY CHRISTOPHER JOHN | Chief Medical Officer | 2023-03-24 | Sale | 700.0 | $35.01 |
| PIMSTONE SIMON N. | Director | 2023-03-07 | Sale | 8,242.0 | $36.94 |
| PIMSTONE SIMON N. | Director | 2023-03-07 | Sale | 10,990.0 | $37.01 |
| PATOU GARY | Director | 2022-11-25 | Sale | 1,937.0 | $34.79 |
| PATOU GARY | Director | 2022-11-23 | Sale | 2,057.0 | $34.33 |
| AULIN SHERRY | Chief Financial Officer | 2022-09-02 | Sale | 15,355.0 | $39.57 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-09-01 | Sale | 8,776.0 | $38.8 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-09-01 | Sale | 35,103.0 | $38.03 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-08-31 | Sale | 21,352.0 | $38.57 |
| PIMSTONE SIMON N. | Director | 2022-08-16 | Sale | 20,000.0 | $38.87 |
| PIMSTONE SIMON N. | Director | 2022-08-16 | Sale | 32,058.0 | $38.29 |
| PIMSTONE SIMON N. | Director | 2022-08-15 | Sale | 33,942.0 | $37.76 |
| EMPFIELD JAMES R. | EVP, Drug Discovery | 2022-08-12 | Sale | 21,875.0 | $38.68 |
| EMPFIELD JAMES R. | EVP, Drug Discovery | 2022-08-12 | Sale | 35,868.0 | $38.08 |
| PIMSTONE SIMON N. | Director | 2022-08-12 | Sale | 1,000.0 | $39.15 |
| PIMSTONE SIMON N. | Director | 2022-08-12 | Sale | 47,000.0 | $38.6 |
| PIMSTONE SIMON N. | Director | 2022-08-12 | Sale | 43,135.0 | $37.91 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,500.0 | $30.8 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,500.0 | $30.5 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,500.0 | $30.55 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,500.0 | $30.2 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,500.0 | $30.1 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,500.0 | $3.8 |
| PIMSTONE SIMON N. | Director | 2022-03-08 | Sale | 2,051.0 | $30.6 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 2,500.0 | $30.55 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 7,500.0 | $30.5 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 2,500.0 | $30.52 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 4,516.0 | $30.44 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 4,516.0 | $30.45 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 4,517.0 | $30.49 |
| PIMSTONE SIMON N. | Director | 2022-03-07 | Sale | 5,037.0 | $30.6 |
| EMPFIELD JAMES R. | EVP, Drug Discovery | 2022-03-07 | Sale | 31,048.0 | $30.54 |
| EMPFIELD JAMES R. | EVP, Drug Discovery | 2022-03-07 | Sale | 1,805.0 | $30.62 |
| PIMSTONE SIMON N. | Director | 2022-03-04 | Sale | 4,793.0 | $30.56 |
| PIMSTONE SIMON N. | Director | 2022-03-04 | Sale | 4,532.0 | $30.66 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-03-04 | Sale | 5,000.0 | $30.23 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-03-04 | Sale | 5,000.0 | $31.05 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-03-04 | Sale | 5,000.0 | $30.15 |
| ROBIN SHERRINGTON | EVP, Strategy & Innovation | 2022-03-04 | Sale | 6,710.0 | $30.56 |
| EMPFIELD JAMES R. | EVP, Drug Discovery | 2022-03-04 | Sale | 18,315.0 | $30.79 |
| KENNEY CHRISTOPHER JOHN | Chief Medical Officer | 2022-01-21 | Purchase | 700.0 | $28.81 |
| Von Seggern Christopher | Chief Commercial Officer | 2021-12-06 | Purchase | 4,000.0 | $24.4 |
| PIMSTONE SIMON N. | Director | 2021-11-15 | Sale | 17,557.0 | $31.33 |